Belgium· BE-AMP-SAM588613-00
Verquvo 2.5 mg
A vericiguat product containing vericiguat, registered in Belgium by Bayer. The same ATC class is registered in 15 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Vericiguat is registered in 15 of 19 countries.
Countries holding a registration under ATC C01DX22 (vericiguat), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 9 of them publish a price we can compare per daily dose
Vericiguat · ATC C01DX22
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of vericiguat costs, country by country.
Normalised to the WHO defined daily dose (10 mg), so markets compare like for like.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Vericiguat · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$12.83
- ES Spain$9.99
- IT Italy$9.50
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Vericiguat
- Manufacturer
- Bayer
- Country
- Belgium (BE)
- ATC code
- C01DX22
- ATC class
- Vericiguat
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb4407573
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vericiguat in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaVERQUVOBayer AG, Leverkusen
- SpainVERQUVO 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULABayer Ag
- FinlandVerquvoBayer AG
- IrelandVerquvo 2.5 mg film-coated tabletsBayer AG
- IcelandVerquvoBayer AG*
- NetherlandsVerquvo 2,5 mg filmomhulde tablettenBayer AG
- NorwayVerquvoBayer AG
- PolandVerquvoBayer AG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Verquvo
- Liechtenstein · Verquvo
- Norway · Verquvo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c7bcb7ea-4ffc-43e7-82a6-823d6aa272a3 GET /v1/drugs/c7bcb7ea-4ffc-43e7-82a6-823d6aa272a3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Verquvo 2.5 mg",
"name_fr": "Verquvo 2.5 mg",
"name_nl": "Verquvo 2.5 mg",
"amp_code": "SAM588613-00",
"strengths": [
"2.5000",
"58.1400"
],
"pack_count": 11,
"substances": [
"Vericiguat",
"Lactose",
"Sodium Laurilsulfate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Vericiguat",
"authorisation_numbers": [
"EU/1/21/1561/001",
"EU/1/21/1561/003",
"EU/1/21/1561/010",
"EU/1/21/1561/002",
"EU/1/21/1561/005",
"EU/1/21/1561/008",
"EU/1/21/1561/007",
"EU/1/21/1561/009",
"EU/1/21/1561/004",
"EU/1/21/1561/006",
"EU/1/21/1561/011"
]
}See everything about vericiguat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.